These discoveries highlight the AMPK/SIRT1/PGC‐1α system as a key controller of diabetes development, presenting new treatment possibilities that target insulin function, sugar processing, and fat regulation through precise pathway adjustments. This evidence concerns the gene SIRT1 and diabetes mellitus.